PHIN:NYSEPHINIA Inc. Analysis
Data as of 2026-05-29 - not real-time
$77.26
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
PHINIA Inc. is trading at $77.26, comfortably above its 20‑day and 50‑day SMAs ($76.67 and $72.71) and well above the 200‑day SMA ($63.99), indicating a bullish price structure despite a bearish MACD histogram. Support sits near $71.21 while resistance is around $80.93, leaving room for upside, and the DCF‑derived fair value of $85.60 suggests roughly a 14‑% discount to intrinsic value. Volume is trending lower, and the 30‑day volatility of 34% combined with a beta above 1 points to heightened price swings, but the market sentiment is in the “Extreme Greed” zone (Fear‑Greed Index 94).
Fundamentally, PHIN posted 10.3% revenue growth to $3.56 B and an adjusted EBITDA of $488 M, with forward EPS projected at $6.76, driving a forward P/E of 11.4. The company maintains a modest dividend yield of 1.55% with a 31% payout ratio, and free cash flow of $190 M supports dividend sustainability. Recent earnings beat estimates and an upgrade to Zacks Rank 1 Strong Buy reinforce the growth narrative, while a debt‑to‑equity of 67% and a max drawdown of ~21% temper enthusiasm.
Fundamentally, PHIN posted 10.3% revenue growth to $3.56 B and an adjusted EBITDA of $488 M, with forward EPS projected at $6.76, driving a forward P/E of 11.4. The company maintains a modest dividend yield of 1.55% with a 31% payout ratio, and free cash flow of $190 M supports dividend sustainability. Recent earnings beat estimates and an upgrade to Zacks Rank 1 Strong Buy reinforce the growth narrative, while a debt‑to‑equity of 67% and a max drawdown of ~21% temper enthusiasm.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price above short‑term moving averages with support at $71.21
- Technical bullish trend despite bearish MACD signal
- Current discount to DCF fair value (~14%)
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth of 10% and forward EPS upside
- Analyst consensus targets ($88‑$92) above current price
- Sustainable dividend and improving cash flow generation
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to intrinsic DCF estimate
- Strong market position in fuel‑system and aftermarket segments
- Resilient earnings outlook despite cyclical sector exposure
Key Metrics & Analysis
Financial Health
Revenue Growth10.30%
Profit Margin3.96%
P/E Ratio21.6
ROE9.14%
ROA5.43%
Debt/Equity67.08
P/B Ratio1.8
Op. Cash Flow$325.0M
Free Cash Flow$189.8M
Technical Analysis
TrendBullish
RSI55.9
Support$71.21
Resistance$80.93
MA 20$76.67
MA 50$72.71
MA 200$64.00
MACDBearish
VolumeDecreasing
Fear & Greed Index94.07
Valuation
Fair Value$85.60
Target Price$88.75
Upside/Downside14.87%
GradeUndervalued
TypeBlend
Dividend Yield1.55%
Risk Assessment
Beta1.17
Volatility34.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.